|
1
|
Brodsky RA and Jones RJ: Aplastic anaemia.
Lancet. 365:1647–1656. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young NS, Calado RT and Scheinberg P:
Current concepts in the pathophysiology and treatment of aplastic
anemia. Blood. 108:2509–2519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Risitano AM and Perna F: Aplastic anemia:
Immunosuppressive therapy in 2010. Pediatr Rep. 3:e72011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dolberg OJ and Levy Y: Idiopathic aplastic
anemia: Diagnosis and classification. Autoimmun Rev. 13:569–573.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hartung HD, Olson TS and Bessler M:
Acquired aplastic anemia in children. Pediatr Clin North Am.
60:1311–1336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scheinberg P and Young NS: How I treat
acquired aplastic anemia. Blood. 120:1185–1196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guinan EC: Diagnosis and management of
aplastic anemia. Hematology Am Soc Hematol Educ Program.
2011:76–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Korthof ET, Békássy AN and Hussein AA:
Management of acquired aplastic anemia in children. Bone Marrow
Transplant. 48:191–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyadera H and Tokunaga K: Associations of
human leukocyte antigens with autoimmune diseases: Challenges in
identifying the mechanism. J Hum Genet. Aug 20–2015.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song EY, Park S, Lee DS, Cho HI and Park
MH: Association of human leukocyte antigen-DRB1 alleles with
disease susceptibility and severity of aplastic anemia in Korean
patients. Hum Immunol. 69:354–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song EY, Kang HJ, Shin HY, Ahn HS, Kim I,
Yoon SS, Park S, Kim BK and Park MH: Association of human leukocyte
antigen class II alleles with response to immunosuppressive therapy
in Korean aplastic anemia patients. Hum Immunol. 71:88–92. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chapuis B, Von Fliedner VE, Jeannet M,
Merica H, Vuagnat P, Gratwohl A, Nissen C and Speck B: Increased
frequency of DR2 in patients with aplastic anaemia and increased DR
sharing in their parents. Br J Haematol. 63:51–57. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saunthararajah Y, Nakamura R, Nam JM,
Robyn J, Loberiza F, Maciejewski JP, Simonis T, Molldrem J, Young
NS and Barrett AJ: HLA-DR15 (DR2) is overrepresented in
myelodysplastic syndrome and aplastic anemia and predicts a
response to immunosuppression in myelodysplastic syndrome. Blood.
100:1570–1574. 2002.PubMed/NCBI
|
|
14
|
Oguz FS, Yalman N, Diler AS, Oguz R, Anak
S and Dorak MT: HLA-DRB1*15 and pediatric aplastic anemia.
Haematologica. 87:772–774. 2002.PubMed/NCBI
|
|
15
|
Chen C, Lu S, Luo M, Zhang B and Xiao L:
Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms
and childhood susceptibility to acquired aplastic anemia. Acta
Haematol. 128:23–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shao W, Tian D, Liu C, Sun X and Zhang X:
Aplastic anemia is associated with HLA-DRB1*1501 in northern Han
Chinese. Int J Hematol. 71:350–352. 2000.PubMed/NCBI
|
|
17
|
Camitta BM, Thomas ED, Nathan DG, et al:
Severe aplastic anemia: A prospective study of the effect of early
marrow transplantation on acute mortality. Blood. 48:63–70.
1976.PubMed/NCBI
|
|
18
|
International Meeting on Antimicrobial
Chemotherapy in Clinical Practice (ACCP). Santa Margherita Ligure,
Italy. October 27–30, 1999. Proceedings. Int J Antimicrob Agents.
16:257–378. 2000.PubMed/NCBI
|
|
19
|
Peng J, Liu C, Zhu K, Zhu Y, Yu Y, Li J,
Hou M, Chen X, Xu C and Zhang M: The TNF2 allele is a risk factor
to severe aplastic anemia independent of HLA-DR. Hum Immunol.
64:896–901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rehman S, Saba N, Munir Khalilullah S,
Ahmed P and Mehmood T: The frequency of HLA class I and II alleles
in Pakistani patients with aplastic anemia. Immunol Invest.
38:812–819. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kapustin SI, Popova TI, Lyshchov AA,
Myanitov EN, Blinov MN and Abdulkadyrov KM: HLA-DR4-Ala74 beta is
associated with risk and poor outcome of severe aplastic anemia.
Ann Hematol. 80:66–71. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sugimori C, Yamazaki H, Feng X, Mochizuki
K, Kondo Y, Takami A, Chuhjo T, Kimura A, Teramura M, Mizoguchi H,
et al: Roles of DRB1*1501 and DRB1*1502 in the pathogenesis of
aplastic anemia. Exp Hematol. 35:13–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yari F, Sobhani M, Vaziri MZ, Bagheri N,
Sabaghi F and Talebian A: Association of aplastic anaemia and
Fanconi's disease with HLA-DRB1 alleles. Int J Immunogenet.
35:453–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakao S, Yamaguchi M, Saito M, Yasue S,
Shiobara S, Matsuda T, Nitta M and Sasaki M: HLA-DR2 predicts a
favorable response to cyclosporine therapy in patients with bone
marrow failure. Am J Hematol. 40:239–240. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakao S, Takamatsu H, Chuhjo T, Ueda M,
Shiobara S, Matsuda T, Kaneshige T and Mizoguchi H: Identification
of a specific HLA class II haplotype strongly associated with
susceptibility to cyclosporine-dependent aplastic anemia. Blood.
84:4257–4261. 1994.PubMed/NCBI
|
|
26
|
Nakao S, Takami A, Sugimori N, Ueda M,
Shiobara S, Matsuda T and Mizoguchi H: Response to
immunosuppressive therapy and an HLA-DRB1 allele in patients with
aplastic anaemia: HLA-DRB1*1501 does not predict response to
antithymocyte globulin. Br J Haematol. 92:155–158. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ihan O, Beksaç M, Arslan O, Ozcan M, Koç
H, Akan H, Gürman G, Konuk N and Uysal A: HLA DR2: A predictive
marker in response to cyclosporine therapy in aplastic anemia. Int
J Hematol. 66:291–295. 1997. View Article : Google Scholar : PubMed/NCBI
|
